BNP Paribas Financial Markets’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,196
| Closed | -$26.8K | – | 4608 |
|
|
2019
Q2 | $26.8K | Sell |
5,196
-4,471
| -46% | -$20.1K | ﹤0.01% | 3788 |
|
|
2019
Q1 | $34.8K | Buy |
9,667
+9,652
| +64,347% | +$41.8K | ﹤0.01% | 3706 |
|
|
2018
Q4 | $92 | Sell |
15
-1,402
| -99% | -$8.55K | ﹤0.01% | 4194 |
|
|
2018
Q3 | $8.28K | Sell |
1,417
-111
| -7% | -$555 | ﹤0.01% | 3823 |
|
|
2018
Q2 | $6.49K | Sell |
1,528
-7,455
| -83% | -$37.6K | ﹤0.01% | 3975 |
|
|
2018
Q1 | $39.6K | Buy |
8,983
+186
| +2% | +$830 | ﹤0.01% | 3672 |
|
|
2017
Q4 | $46.3K | Buy |
8,797
+5,252
| +148% | +$32.1K | ﹤0.01% | 3708 |
|
|
2017
Q3 | $21.7K | Buy |
3,545
+244
| +7% | +$1.54K | ﹤0.01% | 3554 |
|
|
2017
Q2 | $23.9K | Buy |
3,301
+3,255
| +7,076% | +$20K | ﹤0.01% | 3567 |
|
|
2017
Q1 | $244 | Sell |
46
-1,737
| -97% | -$11.7K | ﹤0.01% | 3941 |
|
|
2016
Q4 | $12.8K | Sell |
1,783
-688
| -28% | -$5.56K | ﹤0.01% | 3351 |
|
|
2016
Q3 | $23.1K | Buy |
2,471
+1,161
| +89% | +$9.64K | ﹤0.01% | 2803 |
|
|
2016
Q2 | $8.28K | Buy |
+1,310
| New | +$8.43K | ﹤0.01% | 3000 |
|
|
2016
Q1 | – | Sell |
-5,704
| Closed | -$31.8K | – | 3324 |
|
|
2015
Q4 | $31.8K | Sell |
5,704
-642
| -10% | -$4.24K | ﹤0.01% | 3094 |
|
|
2015
Q3 | $53.7K | Buy |
6,346
+3,880
| +157% | +$65.7K | ﹤0.01% | 2807 |
|
|
2015
Q2 | $37.3K | Buy |
2,466
+1,785
| +262% | +$25.8K | ﹤0.01% | 2663 |
|
|
2015
Q1 | $10.9K | Buy |
+681
| New | +$12.1K | ﹤0.01% | 2700 |
|
|
2014
Q4 | – | Sell |
-1,280
| Closed | -$12.9K | – | 3619 |
|
|
2014
Q3 | $12.9K | Buy |
+1,280
| New | +$15.5K | ﹤0.01% | 3455 |
|
|
2014
Q2 | – | Sell |
-45
| Closed | -$620 | – | 4012 |
|
|
2014
Q1 | $620 | Buy |
45
+38
| +543% | +$761 | ﹤0.01% | 2991 |
|
|
2013
Q4 | $134 | Buy |
+7
| New | +$142 | ﹤0.01% | 4045 |
|
Other funds holding PETX
BNP Paribas Financial Markets's PETX Position: Q3 2019 in Review
BNP Paribas Financial Markets sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 5,196 shares — an estimated $26.8K sold.
BNP Paribas Financial Markets first reported a position in PETX in Q4 2013 and held it in 20 quarters. The position peaked at $53.7K in Q3 2015. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- BNP Paribas Financial Markets reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 5,196 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $26.8K.
- BNP Paribas Financial Markets first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 20 quarters.
- BNP Paribas Financial Markets's Aratana Therapeutics, Inc. position peaked at $53.7K in Q3 2015.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.